| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |